Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
BridgeBio
Pharma
BioMarin touts pipeline asset as potential Voxzogo replacement
Competition is coming for BioMarin’s Voxzogo, but it may be able to answer with a longer-acting version of the drug, which treats a form of dwarfism.
Kevin Dunleavy
Aug 5, 2025 11:30am
Alnylam's market cap jumps past $50B
Aug 1, 2025 7:39am
Alnylam's Amvuttra off to promising start in ATTR-CM
May 1, 2025 11:46am
BridgeBio's Attruby has 'found a place' in ATTR-CM market: CEO
Apr 30, 2025 8:46am
BridgeBio's Attruby off to strong start as it challenges Pfizer
Feb 20, 2025 11:23am
Market growth will help spark sales of Amvuttra, Alnylam says
Feb 13, 2025 2:08pm
